论文部分内容阅读
据报告用干扰素(IF)治疗病毒性疾病和肿瘤有良好效果,表明在不久的将来对人 IF的需求将增加,用人血白细胞或人二倍体细胞株制备的 IF,不能供给大量 IF 作治疗试验和在人体中的应用。已发现人的类淋巴母细胞 Namalva 株用仙台病毒诱生能产生高效价的 IF,其性状和人白细胞 IF 相似,此细胞在长期悬浮培养中生长良好。本文报告将
It has been reported that the treatment of viral diseases and tumors with interferon (IF) has been shown to be effective, indicating that the demand for human IF will increase in the near future and that IF prepared using human blood leukocytes or human diploid cell lines can not supply large amounts of IF Treatment trials and their use in the human body. It has been found that human lymphoblastoid Namalva strains are induced with Sendai virus to produce high titer IFs with similar traits as human leukocyte IF, which grow well in long-term suspension cultures. This report will be